Ryan D. Lake, CPA
LNDC 10.03.2024
About Gravity Analytica
Recent News
- 01.17.2025 - Lifecore Biomedical Announces Special Stockholder Meeting
- 01.07.2025 - Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
- 01.06.2025 - Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
Recent Filings
Ryan D.Lake, CPA
Ryan Lake brings more than 20 years of senior financial and strategic life sciences leadership to Lifecore and is accomplished in leading and advising corporations through mergers; acquisitions; spin-offs; recapitalizations; integrations; real estate; sale-leaseback; equity; debt; and stock market transactions. Mr. Lake has executive responsibility for all finance and accounting functions, SEC reporting, legal, investor relations, and information technology and security.
Prior to joining Lifecore in September 2024, Mr. Lake served as the CFO of Societal CDMO, Inc. (formerly Recro Pharma, Inc.), a global, publicly traded pharmaceutical contract development and manufacturing organization, from January 2018 until its sale and integration with CoreRx, Inc. in May 2024. Mr. Lake also concurrently served as the Chief Financial Officer of Baudax Bio, Inc., a publicly traded specialty pharmaceutical company, taking the company public through a spin-out from Recro Pharma, Inc. from November 2019 to March 2021.
Previously, Mr. Lake served as Societal’s Senior Vice President of Finance and Chief Accounting Officer from June 2017 to January 2018. Prior to joining Societal, Mr. Lake served as CFO and Vice President of Finance of Aspire Bariatrics, Inc., a privately-held, commercial-stage, medical device company from July 2015 to June 2017. From 2012 to 2015, Mr. Lake held executive management and senior finance positions, including Director of the Natural Materials Division, Controller and Senior Director of Finance, at DSM Biomedical (successor to Kensey Nash Corporation after its acquisition in 2012), a division of Royal DSM (listed on Euronext Amsterdam), a global science-based company active in health, nutrition and materials. From 2002 to 2012, Mr. Lake held various senior financial positions of increasing responsibility, most notably Interim Chief Financial Officer and Senior Director of Finance, with Kensey Nash Corporation, a Nasdaq- listed global medical device company. Earlier in his career, Mr. Lake worked at Deloitte & Touche, LLP. Mr. Lake has a B.S. degree in Accounting from West Chester University of Pennsylvania and is a certified public accountant and chartered global management accountant.